Reduced Risk of Human Lung Cancer by Selective Cyclooxygenase 2 (Cox-2) Blockade: Results of a Case Control Study
We conducted a case control study of selective cyclooxygenase-2 (COX-2) blocking agents and lung cancer. A total of 492 newly diagnosed lung cancer cases were ascertained during January 1, 2002 to September 30, 2004, at The Ohio State University Medical Center, Columbus, Ohio. All cases were confirm...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Ivyspring International Publisher
2007
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1893117/ |